US Patent 10927379 Combination therapy with liposomal antisense oligonucleotides
Patent 10927379 was granted and assigned to Bio-Path Holdings on February, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 15, 2017
0
Date of Patent
February 23, 2021
0
Patent Applicant
Patent Application Number
16333221
0
Patent Citations Received
Patent Inventor Names
Ana Tari Ashizawa
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10927379 Combination therapy with liposomal antisense oligonucleotides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
